carolinaspsychiatricinstitute.com

Research Services

Advancing Evidence-Based Mental Health Care Through Scientific Excellence & Community Mental Health Leadership

Advancing Evidence-Based Mental Health Care Through Scientific Excellence

At Carolinas Psychiatric Institute, psychiatric research is at the heart of innovation, clinical excellence, and compassionate patient care. Under the leadership of Ritvij Satodiya, MD, our research division is dedicated to advancing the field of psychiatry through rigorous scientific inquiry, evidence-based practices, and meaningful collaboration.

Dr. Satodiya is a distinguished leader in mental health research, driven by an unwavering commitment to expanding psychiatric knowledge and improving clinical outcomes. Actively engaged in clinical research, psychopharmacology studies, and evidence-based treatment development, he continuously explores modern psychiatric breakthroughs and translates them into real-world patient care.

Our research initiatives emphasize cutting-edge psychiatric treatments, ethical research methodologies, and data-driven innovation ensuring that the latest scientific advancements directly benefit individuals, families, and communities.

Research Expertise & Focus Areas

Clinical Research & Innovation in Psychiatry

Dr. Satodiya actively conducts and contributes to clinical trials and psychiatric studies, focusing on novel treatments, medication efficacy, and emerging therapeutic models. His work supports the development of safer and more effective interventions for complex mental health conditions.

Evidence-Based Psychiatry

A strong advocate for evidence-based mental health care, Dr. Satodiya integrates validated research findings into everyday clinical practice, maintaining the highest standards of psychiatric treatment and patient safety.

Academic Contributions & Knowledge Dissemination

Dr. Satodiya regularly publishes in peer-reviewed psychiatric journals and presents at national and international psychiatric conferences, sharing insights with clinicians, researchers, and academic institutions worldwide.

Research Offerings

Our psychiatry research services include:

  • Clinical Trials & Psychiatric Studies
    • Designing, implementing, and interpreting clinical research focused on innovative psychiatric treatments and interventions.
  • Systematic Literature Reviews & Meta-Analyses
    • Comprehensive reviews synthesizing existing psychiatric research to guide best practices and clinical decision-making.
  • Evidence-Based Therapy Development
    • Translating psychiatric research findings into practical, effective, and patient-centered therapeutic approaches.
  • Psychopharmacology Research
    • Advanced expertise in studying psychiatric medications, including mechanisms of action, side-effect profiles, and treatment outcomes.
  • Grant Writing & Research Funding Acquisition
    • Proven experience securing funding from public and private organizations to support impactful psychiatric research initiatives.
  • Mentorship & Research Training
    • Guiding early-career researchers, psychiatry residents, and medical professionals in ethical research practices and study design.
  • Collaborative & Multicenter Research
    • Leadership and participation in interdisciplinary and multi-institutional psychiatric research collaborations.
  • Publication & Scientific Communication
    • Drafting high-impact manuscripts for peer-reviewed journals and presenting findings at global psychiatric conferences.

Selected Peer-Reviewed Publications

September 2025

Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD).

Cureus.

Bied A, Sakthivel AA, Satodiya R.

March 2024

Systematic Review of Multisystemic Therapy in Adolescent Sex Offenders.

Journal of the American Academy of Psychiatry and the Law.

Satodiya R., Bied A, Shah K, Parikh T, Ash P.

January 2024

Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence.

Current Psychopharmacology.

Bourji, H. E., Farhat, A., Hamdan, Z., Satodiya, R., Shukla, R., & El Hayek, S.

May 2023

Lumateperone for treatment of psychotic symptoms in Lewy body disease: A case report.

Journal of Clinical Psychopharmacology.

Bied AM, Njuguna SW, Satodiya RM.

February 2023

Development of Atypical Neuroleptic Malignant Syndrome after Treatment of Cocaine Intoxication: A Case Report and Literature Review.

Cureus.

Miller M, Zezetko A, Satodiya R.

December 2022

Training in the time of COVID-19: Yearning for Closure.

Psychiatric News.

Satodiya R.

October 2022

A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight.

Journal of Clinical Psychopharmacology.

Satodiya RM, Brown VR, Njuguna SW, Bied AM.

August 2022

A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight.

Journal of Clinical Psychopharmacology.

Satodiya RM, Brown VR, Njuguna SW, Bied AM.

February 2022

Autism in a Child With X-linked Agammaglobulinemia.

Cureus.

Bied A, Njuguna S, Satodiya R.

January 2021

Education in Isolation.

NYCCAP Newsletter.

Satodiya R.

December 2020

Priapism in Sickle Cell Trait With High Sensitivity to Multiple Psychotropic Medications.

Journal of Clinical Psychopharmacology.

Satodiya R, Yacoub A.

How Psychiatrists Can Guide Distance Learning.

Psychiatric Times.

Satodiya R.

September 2020

Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia.

Cureus.

Satodiya R, Palekar N.

January 2017

Disaster Mental Health and Positive Psychology: An Afterward to the Special Issue.

Chronic Stress Journal.

Averill CL, Satodiya RM, Scott JC, Wrocklage KM, Schweinsburg B, Averill LA, Akiki TJ, Amoroso T, Southwick SM, Krystal JH, Abdallah CG.

December 2016

Posttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat Veterans.

Journal of Clinical Psychology.

Southwick SM, Satodiya R, Pietrzak RH.